Navigation Links
BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
Date:7/17/2009

may not have positive results; that we or our licensees may not be able to continue future development of our current and future development programs; that our development programs may never result in future product, license or royalty payments being received by BioCryst; that BioCryst may not be able to retain its current pharmaceutical and biotechnology partners for further development of its product candidates or it may not reach favorable agreements with potential pharmaceutical and biotechnology partners for further development of its product candidates; that our actual burn rate may not be consistent with our expectations; that BioCryst may not have sufficient cash to continue funding the development, manufacturing, marketing or distribution of its products and that additional funding, if necessary, may not be available at all or on terms acceptable to BioCryst. Please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst's most recent Annual Report on Form 10-K, most recent Registration Statement on Form S-3 (filed November 28, 2008 and subsequently amended Jan 23, 2009), Quarterly Reports on Form 10-Q, and current reports on Form 8-K, all of which identify important factors that could cause the actual results to differ materially from those contained in our projections and forward-looking statements.


'/>"/>
SOURCE BioCryst Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
2. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
3. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
4. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
5. BioCryst Updates Peramivir Clinical Development Plan
6. BioCryst Provides Forodesine HCl Update
7. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
8. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
9. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
10. Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
11. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2015)... THE WOODLANDS, Texas , Aug. 3, 2015 ... today announced that the pivotal TELESTAR Phase 3 ... benefit of oral telotristat etiprate in treating cancer ... controlled by the current standard of care. Telotristat ... on Nobel Prize-winning technology, and is the company,s ...
(Date:7/31/2015)... More than 1,500 substance abuse prevention and ... Indianapolis Aug. 2-6 for Community ... Institute . The week-long training, held at the JW ... our nation,s biggest public health challenges – youth drug ... a one-of-a-kind intensive training opportunity, offering more than 70 ...
(Date:7/31/2015)...  Boston Children,s Hospital physicians report the first ... their anatomy before undergoing high-risk brain procedures. The ... the brain,s blood vessels) that posed special treatment ... Journal of Neurosurgery: Pediatrics , the physicians ... resins to create custom, high-fidelity models of the ...
Breaking Medicine Technology:Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 23D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4
... , SILVER SPRING, Md. , May 6 The Food and Drug Administration (FDA) ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , ... Certain external defibrillators that were recalled because they may malfunction during ... , , ...
... Academy Award, Emmy Award, and Golden Globe Award-nominated actress Lorraine ... a 30-minute public affairs television program that tells the compelling and inspirational stories ... stations nationwide. , , , ... for her gritty portrayal of mob wife Karen Hill in the ...
Cached Medicine Technology:FDA CONSUMER HEALTH INFORMATION - FDA's MedWatch Safety Alerts: April 2010 2FDA CONSUMER HEALTH INFORMATION - FDA's MedWatch Safety Alerts: April 2010 3'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 2'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 3'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 4'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 5'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 6'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 7'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 8'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 9'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 10'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 11'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 12'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 13
(Date:8/3/2015)... Asbury Park, NJ (PRWEB) , ... August 03, ... ... is pleased to announce the development of it’s new program “Designing Secure Healthcare ... provide software architects, engineers and technology leaders from healthcare organizations with access to ...
(Date:8/3/2015)... ... , ... A July 13 article from The Daily Mail titled "Jab ... That Can Last 'For Five Weeks'" discusses the use of stem cells to ... that harvesting stem cell-rich bone marrow from the hip, known as bone marrow stromal ...
(Date:8/3/2015)... Ramon, CA (PRWEB) , ... August 03, 2015 ... ... leading global insurance brokerage firm, announced today that Joe Williams has joined its ... development, sales, and delivering HUB's differentiated service model to his clients. Mr. Williams ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... management and investigative services, has introduced a new logo and comprehensive brand ... that improve business outcomes for its customers. EMSI’s new tagline, “Powerful Information. ...
(Date:8/2/2015)... ... August 03, 2015 , ... Career Step, an online ... the Association for Healthcare Documentation Integrity’s (AHDI) conference being held in Alexandria, Virginia, ... opportunity the AHDI conference provides us to interact with those in the healthcare ...
Breaking Medicine News(10 mins):Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2
... research by University of Leeds scientists (UK) discovers that a ... bodies to make their own medicine// and there will soon ... Simon Carding of Leeds' Faculty of Biological Sciences has adapted ... a treatment for Inflammatory Bowel Disease (IBD). Bacteria and viruses ...
... dozen people have taken ill and have been hospitalized in ... ‘ baseless’ by spokesman Xiong Yuanda of the Health Bureau ... infectious ‘unknown’ disease, doing the rounds in the city, as ... bureau has sought to dispel reports carried by a famous ...
... scientist, Simon Carding, has genetically altered or designed bacteria ... , The bacterium ; Bacterium ovatus, one of ... to produce human growth factors called cytokines. These were ... damaged by the disease, hence reducing the inflammation. ...
... food allergies are the reasons for many common ailments among ... British residents who have encountered health related issues due to ... it was found out that food intolerance is the root ... intolerance is one of the common forms of food intolerance. ...
... care homes are not being properly attended to in London. As ... in hunger// for most of the time. This was disclosed by ... older people’ campaign Mr. Lewis said that issues during the meal ... is kept far from an old person and nobody is around ...
... an Indian Army officer has become the first person to ... Service//. ,Major S.K. Singh of the Regiment of Artillery ... was declared brain dead at the premier Army Hospital (Research ... statement said. ,The elder Singh was suffering ...
Cached Medicine News:Health News:A Spoonful Of Sugar to 'Switch' the Bacteria on and Off 2Health News:‘Sweet Revenge’ on Inflammatory Bowel Disea 2
The ENDO CLOSE™ trocar site closure device has application in laparoscopic procedures for approximation of tissues and percutaneous suturing for closing incision sites....
... of a 42" long suture inserted into a ... one end and scored on the other. The ... to a ST-3 needle. The opposite end of ... of the plastic tube. The scored end acts ...
... long ligature inserted into a plastic tube. The plastic ... the other. The suture protrudes from the narrow end ... knot which becomes secure after the device is activated. ... the scored end of the plastic tube. The scored ...
... consists of 18'' long ligature inserted into a plastic ... and scored on the other. The suture protrudes from ... loop with a knot which becomes secure after the ... is fastened to the scored end of the plastic ...
Medicine Products: